Cargando…
Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020.
The Strategic Health and Environment Plan 2022-2026 (PESMA), approved in November 2021 by the Interterritorial Council of the National Health System, and its 1(st) Action Program (2022-2023), include in one of its lines of intervention is the description of the rates of incidence, prevalence, mortal...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ministerio de Sanidad
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541264/ |
_version_ | 1785113879474339840 |
---|---|
author | Vargas Marcos, Francisco Mendoza García, Marian |
author_facet | Vargas Marcos, Francisco Mendoza García, Marian |
author_sort | Vargas Marcos, Francisco |
collection | PubMed |
description | The Strategic Health and Environment Plan 2022-2026 (PESMA), approved in November 2021 by the Interterritorial Council of the National Health System, and its 1(st) Action Program (2022-2023), include in one of its lines of intervention is the description of the rates of incidence, prevalence, mortality and morbidity of diseases that, supposedly, could be associated with exposure to low-frequency electromagnetic fields (EMF), which are used in transport lines electricity, transformers and household appliances, and with radio frequencies (mobile phones, base stations, Wi-Fi, etc.). |
format | Online Article Text |
id | pubmed-10541264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Ministerio de Sanidad |
record_format | MEDLINE/PubMed |
spelling | pubmed-105412642023-10-06 Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. Vargas Marcos, Francisco Mendoza García, Marian Rev Esp Salud Publica Reseña The Strategic Health and Environment Plan 2022-2026 (PESMA), approved in November 2021 by the Interterritorial Council of the National Health System, and its 1(st) Action Program (2022-2023), include in one of its lines of intervention is the description of the rates of incidence, prevalence, mortality and morbidity of diseases that, supposedly, could be associated with exposure to low-frequency electromagnetic fields (EMF), which are used in transport lines electricity, transformers and household appliances, and with radio frequencies (mobile phones, base stations, Wi-Fi, etc.). Ministerio de Sanidad 2023-04-12 /pmc/articles/PMC10541264/ Text en https://creativecommons.org/licenses/by-nc-nd/3.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons |
spellingShingle | Reseña Vargas Marcos, Francisco Mendoza García, Marian Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. |
title | Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. |
title_full | Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. |
title_fullStr | Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. |
title_full_unstemmed | Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. |
title_short | Síntesis del Informe Mortalidad por leucemias, Linfomas no Hodgkin y tumores del Sistema Nervioso Central en España. 2001-2020. |
title_sort | síntesis del informe mortalidad por leucemias, linfomas no hodgkin y tumores del sistema nervioso central en españa. 2001-2020. |
topic | Reseña |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541264/ |
work_keys_str_mv | AT vargasmarcosfrancisco sintesisdelinformemortalidadporleucemiaslinfomasnohodgkinytumoresdelsistemanerviosocentralenespana20012020 AT mendozagarciamarian sintesisdelinformemortalidadporleucemiaslinfomasnohodgkinytumoresdelsistemanerviosocentralenespana20012020 |